We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Eurofins Technologies

Eurofins Technologies, part of the Eurofins Scientific group, is a fast-growing, global provider of diagnostic test k... read more Featured Products: More products

Download Mobile App





Eurofins Launches Reagents for Automated Extraction of Genomic SARS-CoV-2 RNA from Clinical Swab Samples

By LabMedica International staff writers
Posted on 10 Aug 2020
Eurofins Technologies (Luxembourg) has launched reagents for automated isolation of high-quality SARS-CoV-2 RNA (ribonucleic acid) from viral particles of human respiratory specimens.

As COVID-19 continues to accelerate worldwide, diagnostic laboratories face an unprecedented demand for testing capacity. More...
Eurofins' launch of the GSD NovaPrime RNA Extraction kits aims to help laboratories to meet this demand with an easy and highly efficient extraction method that works with a large range of existing automation equipment.

The GSD NovaPrime RNA Extraction AE1 kit is intended for the automated extraction of genomic SARS-CoV-2 RNA from human respiratory (nasal wash/swab, nasopharyngeal wash/swab, oropharyngeal swab) specimen types, specifically validated for the use with the KingFisher Flex System automation platform. The GSD NovaPrime RNA Extraction AE2 kit is intended for automated extraction of genomic SARS-CoV-2 RNA from human respiratory (nasal wash/swab, nasopharyngeal wash/swab, oropharyngeal swab) specimen types, specifically validated for the use with the MGI MGISP-960 automation platform.

The reagents’ magnetic bead-based, automated method extracts and isolates virus particles and their respective RNA on many open platforms for subsequent real-time RT-PCR (reverse transcription polymerase chain reaction) analysis using approved IVD kits. Both the kits are ideal for use with the GSD NovaPrime SARS-CoV-2 (COVID-19) RT-PCR clinical IVD assay for virus detection. The kits have to be validated as required by local legislation for their intended use by authorized clinical testing laboratories. Eurofins also plans to release a CE-IVD marked version of the kit at a later stage.

Related Links

Eurofins Technologies


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.